Two trades to watch: Nasdaq, HSBC

Nasdaq edges lower with Microsoft and Alphabet earnings in focus

After a weak start yesterday, the Nasdaq managed to finish the day 1.3% higher, and futures are rising again today.

Yesterday, the index was in focus as Elon Musk reached an agreement to buy Twitter for $44 billion in an apparent U-turn by the board.

US tech earnings begin in earnest today with the release of results from Microsoft and Alphabet. Big tech is expected to see growth deteriorate in 2022 amid rising inflation, a higher interest rate environment, and ongoing supply chain disruption. However, Microsoft is an exception and is forecast to deliver record growth; even so, the share price has underperformed.

Google parent Alphabet is expected to report EPS of $25.63 on revenue of $68.13 billion.

MSTF is expected to report EPS of $2.18 on revenue of $49.03 billion.

The performance and outlook for these two tech giants will be key is deciding where the tech heavy Nasdaq goes from here.

Where next for the Nasdaq?

After facing rejection at 15260, mildly above the 200 SMA, the price fell lower. The falling below the 50 SMA combined with the bearish RSI keeps sellers optimistic about further downside.

The price found a low yesterday of 13180, which can now be considered the near-term support, with a break below here opening the door to 12950, the 2022 low.

Buyers will be looking for a move over 13750, a level that has offered support and resistance on several occasions across this year. A move above here exposes the 50 sma at 14140, which could lead to the creation of a higher high and lift the price towards 14650.

HSBC falls as profits tumble

Europe’s largest bank reported a 27% fall in pre-tax profits in the first three months of this year to $4.2 billion, down from $5.78 billion a year earlier. The results were, in fact, ahead of forecasts of $5.72 billion.

While stronger lending and personal banking operations helped boost earnings, a rise in expected credit loss to $600 million, on the back of the fallout from the Russian war and China’s real estate woes, hit earnings, particularly when compared to last year when the bank unlocked ECL to the tune of $400 million.

HSBC disappointed investors by removing the prospect of further buyback this year, blaming the volatility in some investments.

The bank, which makes around 60% of its profits from Asia, faces plenty of headwinds with COVUD cases and lockdowns threatening growth in Asia while surging inflation and higher interest rates threaten to slow global growth.

Where next for HSBC share price?

The HSBC share ran into resistance at 530p before falling lower in recent sessions. The share price trades around 8% over the past week.

The share price has fallen through its 50 sma, which along with the bearish RSI suggests that there could be more downside to come.

For now, the price is testing support at the 100 sma, a break below here is needed to bring horizontal support at 475 into focus. A break below here could open the door to 436p the 2022 low.

Should the 100 sma support hold, buyers will look towards 500p the early January high, and yesterday’s low as the next level of resistance before exposing the 50 sma at 510p.

How to trade with City Index

Follow these easy steps to start trading with City Index today:

Open a City Index account, or log-in if you’re already a customer.
Search for the market you want to trade in our award-winning platform.
Choose your position and size, and your stop and limit levels
Place the trade.

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.

City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.

City Index is a trademark of StoneX Financial Ltd.

The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.